Study on the Efficacy and Safety of a Therapeutic Strategy of PPH Comparing Early Administration of Human Fibrinogen vs Placebo in Patients Treated With IV Prostaglandins Following Vaginal Delivery

Trial Profile

Study on the Efficacy and Safety of a Therapeutic Strategy of PPH Comparing Early Administration of Human Fibrinogen vs Placebo in Patients Treated With IV Prostaglandins Following Vaginal Delivery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Acronyms FIDEL
  • Sponsors LFB
  • Most Recent Events

    • 22 Aug 2017 Planned End Date changed from 1 Oct 2017 to 11 Mar 2018.
    • 22 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 11 Mar 2018.
    • 01 Mar 2016 Planned End Date changed from 1 Mar 2016 to 1 Oct 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top